Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma.
In a prospective study designed to differentiate pheochromocytoma from other forms of hypertension, urinary catecholamines were measured after sleep and clonidine administration in 12 patients with pheochromocytoma, 19 hypertensive patients in whom pheochromocytoma was suspected but later excluded, and 31 hypertensive patients in whom pheochromocytoma was never suspected. The test correctly identified all 12 patients in whom pheochromocytoma was present. Four of these had equivocal plasma levels of both norepinephrine and epinephrine, suggesting that overnight clonidine suppression may be of particular value when tumor secretion is intermittent or low. When pheochromocytoma was not present, urinary norepinephrine and epinephrine levels were suppressed below 60 and 20 nmol/mmol creatinine, respectively, after sleep and clonidine, the two in combination giving better suppression than sleep alone. Since urinary catecholamines can be determined relatively easily by high-pressure liquid chromatography with electrochemical detection, this test may be more widely applicable than suppression tests based on plasma measurements.
Macdougall
I C
IC
Department of Biochemistry, Western Infirmary, Glasgow, Scotland.
Isles
C G
CG
Stewart
H
H
Inglis
G C
GC
Finlayson
J
J
Thomson
I
I
Lees
K R
KR
McMillan
N C
NC
Morley
P
P
Ball
S G
SG
D000310:Adrenal Gland Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism*; D003000:Clonidine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D011446:Prospective Studies; D012890:Sleep
D002395:Catecholamines; D003000:Clonidine